Source recordFED

adMare BioInnovations / BioInnovations adMareBioInnovations adMare

Federal grants & contributions· Centre for Drug Research and Development· Innovation, Science and Economic Development Canada· FY2022· $92,000,000· BN 790529937· BC

Description

Funding to continue to grow adMare's pipeline of promising health technologies and create new spin-off companies and train highly qualified personnel in the biopharmaceutical industry.

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$92,000,000$0Original · 2021-04-01 (start date) · total $92,000,000
  • #02021-04-01$92,000,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2021-04-01(start date)$92,000,000—Funding to continue to grow adMare's pipeline of promising health technologies and create new spin-off compani…

Related records · 4

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 790529937)

RefDepartment · programCurrent valueFY
033-2024-2025-Q4-515305Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SSF - Science & Research$5,000,000FY2026
GC-WD-DEO-2024-2025-Q4-14Pacific Economic Development Canada | Développement économique Canada pour le Pacifique · Regional Economic Growth through Innovation$6,000,000FY2025

Other recipients funded under "Centre for Drug Research and Development" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
033-2018-2019-Q4-511806The Centre for Drug Research and Development (CDRD)FY2020$48,000,000FY2020
033-2017-2018-Q1-511357The Centre for Drug Research and Development (CDRD)FY2018$32,000,000FY2018

Cite as: Glassbox record view · Federal grants & contributions · 033-2021-2022-Q4-514176 · retrieved 2026-11-12.